Home / Blog / Tag / Coronary stents

Coronary Stents

Search by Categories

Trending

View All

MedTech News for Epredia, Olympus, Neuralace, Bloomlife
Epredia Announced the US Launch of SlideMate Laser; Olympus, Canon Medical Announced Partnership; FDA Cleared Painful Diabetic Neuropathy Neurostim Therapy from Neuralace; FDA Clearance to Bloomlife’s Bloomlife MFM-Pro; BrainsWay Initiated New Studies of Non-Invasive Neurostim; Gore Enrolled First Patients in Expandable Stent Graft Trial

Epredia Announced the US Launch of SlideMate™ Laser, Providing State-of-the-Art Precision Slide Printing for Pathology Laboratories On January 11, 2024, Epredia, a global leader in precision cancer diagnostics, announced that the company launched US sales of SlideMate™ Laser, the newest addition to the company’s...

Find More
Latest MedTech News for Olympus and Aerin
Aerin Medical’s RhinAer Stylus; CE Mark for Haemonetics’s VASCADE Vascular Closure Device; J&J Vision Launches ACUVUE OASYS MAX 1-Day; Olympus Launches VISERA ELITE III Surgical Visualization Platform; GlucoRx’s Non-Invasive Glucose Monitoring Platform; Medtronic-BioIntelliSense’s Partnership; Corindus’s CorPath GRX Neurovascular System Trial; GE & Lantheus [18F]flurpiridaz PET Radiotracer Trial; Pulmonx’s AeriSeal System Trial; AtriAN’s Second Study on Cardioneuroablation

Johnson & Johnson Vision Launches New Contact Lens Innovation ACUVUE® OASYS MAX 1-Day for Meeting the Needs of Digitally Intense Lifestyles On September 12, 2022, Johnson & Johnson Vision, a part of Johnson & Johnson and a global leader in the eyecare market, had announced the launch of its newest in...

Find More
MedTech News for Miracor, Oticon, and Medtronic
Miracor Medical’s Picso Pivotal Study; Medtronic’s Extravascular ICD; Galaxy Medical’s CENTAURI Pulsed Electric Field System; UltraSight’s Novel Cardiac AI Technology; Oticon Launched the World’s Smallest Hearing Aid; Medtronic Completes Acquisition of Affera

FDA Approved IDE for Picso® Pivotal Study of Miracor Medical On August 23, 2022, Miracor Medical SA, a provider of innovative solutions for the treatment of severe cardiac diseases, announced that the FDA has approved an Investigational Device Exemption (IDE), allowing the company to begin a pivotal study with i...

Find More